CJC-1295 (no DAC) studies
18 journal papers mention CJC-1295 (no DAC) in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.
Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether CJC-1295 (no DAC) is safe, effective or approved for any use.
- Papers
- 18
- 14 articles, 4 reviews
- Earliest paper
- 2005
- Most papers in 2026 (7)
- Open access
- 50%
- free to read somewhere
- Reviews
- 22%
- of all papers listed
What kind of studies
Of 35 papers in PubMed that mention CJC-1295 (no DAC) in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.
- Randomized controlled trials1
- Other clinical trials1
- Meta-analyses and systematic reviews0
- Other reviews11
- Case reports0
- Animal studies only5
- Studies in humans22
Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).
Registered clinical studies
Studies on ClinicalTrials.gov that mention CJC-1295 (no DAC) in their intervention details. A registration says a study is planned or running, not what it found.
- Registered
- 1
- Completed
- 0
- Ongoing or planned
- 0
- Phase 1
- 0
- Phase 2
- 1
- Phase 3
- 0
- A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
NCT00267527TerminatedPhase 2started 2005-12
The five most recently updated studies. See all 1 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.
Papers per year
2005 to 2026, peak 7 papers in a year. The latest year may still be incomplete.
Where it is published
- The American Journal of Sports Medicine2 papers
- The Journal of Clinical Endocrinology & Metabolism2 papers
- Annales de Toxicologie Analytique2 papers
- Talanta1 papers
- Proceedings of the National Academy of Sciences1 papers
The papers
Most citedName in the title
No papers in this list match the filter.
LatestName in title or abstract
- Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review
V Vasylieva, Annette West, Edward Karpman · Sexual Medicine Reviews · 2026
Review
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026
ReviewOpen access · CC BY1 citationsRead the open copy →
- Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Volodymyr Mavrych, Inna Shypilova, Olena Bolgova · Frontiers in Aging · 2026
ReviewOpen access · CC BY5 citationsRead the open copy →
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Omar F. Rahman, Steven J. Lee, William A. Seeds · JAAOS Global Research and Reviews · 2026
ReviewOpen access · CC BY-NC-ND5 citationsRead the open copy →
Each list shows up to 40 papers.See all 18 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.